These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 9173387)
1. [Prognostic factors in radiotherapy of supraglottic cancer]. Składowski K; Zajusz A; Swiatnicka J; Maciejewska M; Krupska T; Majewski S; Szelc S; Swiecki J; Maciejewski B Otolaryngol Pol; 1996; 50(6):579-86. PubMed ID: 9173387 [TBL] [Abstract][Full Text] [Related]
2. [Radiation therapy in glottic laryngeal carcinoma stage. I. Results and analysis of prognostic factors]. Skołyszewski J; Reinfuss M; Kowalska T; Walasek T; Dymek P Otolaryngol Pol; 1996; 50(3):243-7. PubMed ID: 9045160 [TBL] [Abstract][Full Text] [Related]
3. [The effect of primary tumor localization on radiotherapy for supraglottic and glottic cancer]. Goleń M; Trybalska G; Namysłowski G Otolaryngol Pol; 1998; 52(1):45-51. PubMed ID: 9591421 [TBL] [Abstract][Full Text] [Related]
4. Predictors of local failure in early laryngeal cancer. Lohynska R; Slavicek A; Bahanan A; Novakova P Neoplasma; 2005; 52(6):483-8. PubMed ID: 16284693 [TBL] [Abstract][Full Text] [Related]
5. Radiotherapy for carcinoma of the supraglottis. Mendenhall WM; Parsons JT; Stringer SP; Cassisi NJ Otolaryngol Clin North Am; 1997 Feb; 30(1):145-61. PubMed ID: 8995142 [TBL] [Abstract][Full Text] [Related]
6. [External radiotherapy in early stage squamous cell carcinoma of the supraglottic larynx. Report of 28 cases]. Caliceti U; Frezza G; Galuppi A; Guidetti A; Pasquini E; Sorrenti G; Cavicchi O; Rinaldi Ceroni A Acta Otorhinolaryngol Ital; 1996 Feb; 16(1):35-9. PubMed ID: 8984838 [TBL] [Abstract][Full Text] [Related]
7. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension. Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660 [TBL] [Abstract][Full Text] [Related]
8. The role of postradiotherapy neck dissection in supraglottic carcinoma. Chan AW; Ancukiewicz M; Carballo N; Montgomery W; Wang CC Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):367-75. PubMed ID: 11380223 [TBL] [Abstract][Full Text] [Related]
9. Multimodal treatment for t1-2 supraglottic cancer: the impact of tumor location. Suzuki G; Yamazaki H; Ogo E; Abe T; Hayabuchi N; Umeno H; Nakashima T; Nakamura S; Yoshida K Anticancer Res; 2014 Jan; 34(1):203-7. PubMed ID: 24403463 [TBL] [Abstract][Full Text] [Related]
10. Supraglottic carcinoma treated with curative radiation therapy: identification of prognostic groups with MR imaging. Ljumanović R; Langendijk JA; Schenk B; Van Wattingen M; Knol DL; Leemans CR; Castelijns JA Radiology; 2004 Aug; 232(2):440-8. PubMed ID: 15286316 [TBL] [Abstract][Full Text] [Related]
11. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer. Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676 [TBL] [Abstract][Full Text] [Related]
13. Comparative estimation of cure rates for supraglottic and glottic cancer in radiotherapy. Goleń M; Składowski K; Maciejewski B Neoplasma; 1999; 46(1):66-71. PubMed ID: 10355537 [TBL] [Abstract][Full Text] [Related]
14. Transoral carbon dioxide laser supraglottic laryngectomy and irradiation in stage I, II, and III squamous cell carcinoma of the supraglottic larynx: report of Southwest Oncology Group Phase 2 Trial S9709. Agrawal A; Moon J; Davis RK; Sakr WA; Giri SP; Valentino J; LeBlanc M; Truelson JM; Yoo GH; Ensley JF; Schuller DE; Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1044-50. PubMed ID: 17938330 [TBL] [Abstract][Full Text] [Related]
15. Definitive radiotherapy for carcinoma in situ of the true vocal cords. Sengupta N; Morris CG; Kirwan J; Amdur RJ; Mendenhall WM Am J Clin Oncol; 2010 Feb; 33(1):94-5. PubMed ID: 19738453 [TBL] [Abstract][Full Text] [Related]
16. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma. Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306 [TBL] [Abstract][Full Text] [Related]
17. [Exclusive radiotherapy in 250 cases of stage I-II cancers of the supraglottic larynx]. Glínski B; Reinfuss M; Walasek T; Skolyszewski J Bull Cancer Radiother; 1996; 83(3):177-9. PubMed ID: 8977571 [TBL] [Abstract][Full Text] [Related]
18. [Radiotherapy in glottic T1 carcinoma. Local control and survival]. Herranz J; Fernández M; Ramos S; Vázquez Barro C; Sarandeses García A; Martínez Vidal J; Veiras C Acta Otorrinolaringol Esp; 2000; 51(1):57-61. PubMed ID: 10799934 [TBL] [Abstract][Full Text] [Related]
19. Conservative management of T1-T2N0 supraglottic cancer: a retrospective study. Spriano G; Antognoni P; Piantanida R; Varinelli D; Luraghi R; Cerizza L; Tordiglione M Am J Otolaryngol; 1997; 18(5):299-305. PubMed ID: 9282245 [TBL] [Abstract][Full Text] [Related]
20. Radiotherapy for squamous cell carcinoma of the supraglottic larynx: an alternative to surgery. Mendenhall WM; Parsons JT; Mancuso AA; Stringer SP; Cassisi NJ Head Neck; 1996; 18(1):24-35. PubMed ID: 8774919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]